Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...

Move comes 2 years after controversial exit of brand-name product ...

Children with food allergy who used omalizumab plus oral immunotherapy vs. omalizumab alone had similar rates of allergen ...

Nonclinical factors are more likely to drive discontinuation of biologic therapy for patients with severe asthma.

A Professor of Medicine at the Lagos State University, LASU, Ojo, Professor Olufunke Olayinka Adeyeye, has said no fewer than 13 million Nigerians suffer from Asthma, a respiratory disease.

Among patients with asthma without diabetes, the risk for exacerbation was decreased with GLP-1 receptor agonist exposure, ...

Asthma biologic use was not associated with an increase in respiratory infection risk, according to results from the 2026 ...

Asthma and COPD share similar breathing symptoms, often leading to confusion and misdiagnosis. Know key differences, risks of ...

Respiratory physicians Dr Hannah Petty and Dr Nita Sehgal discuss management of treatment resistant asthma in primary care ...

As an add-on maintenance treatment for severe asthma with type 2 inflammation, characterized by blood eosinophil count in adults and adolescents 12 years and older who are inadequately controlled ...

Study results suggest immune checkpoint inhibitor therapy may offer immunomodulatory benefits for patients with asthma and ...